Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Degos

Showing results (221-230 of 331) with videos related to

Pageof 34
Sort By:
Blood|November 1, 1990
All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationshipC Chomienne, P Ballerini, N Balitrand, et al.
Tissue Antigens|February 1, 1975
Combined analysis of three studies of patients with Burkitt's lymphomaJ G Bodmer, W F Bodmer, P Pickbourne, et al.
Cancer|April 15, 1985
Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patientsH Tilly, S Castaigne, D Bordessoule, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1991
[Biological parameters of the efficiency of retinoic acid in acute leukemia]C Chomienne, M Cornic, S Castaigne, et al.
Immunogenetics|January 1, 1986
Correlation between an HLA-DQ alpha length polymorphism of messenger RNA and serologically defined specificities (DQw1, DRw53, DR3+5)P Loiseau, P Lehn, F Dautry, et al.
Blood|October 1, 1986
c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemiaP Lehn, F Sigaux, D Grausz, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Retinoic acids in the treatment of acute promyelocytic leukemiaS Castaigne, C Chomienne, M T Daniel, et al.
Blut|February 1, 1989
alpha-IFN treatment does not induce Ki-ras expression in hairy-cell leukemia patientsM L Giron, G Mercier, F Sigaux, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1984
[Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin]M Marty, G Ganem, J Fischer, et al.
Tissue Antigens|February 1, 1985
Evidence for a new HLA class II determinant present on cells from HLA-DR1 and/or -DR4 individualsV Lepage, D Alcalay, C Douay, et al.
Pageof 34

Showing results (221-230 of 331) with videos related to

Sort By:
Pageof 34
Blood|November 1, 1990
All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationshipC Chomienne, P Ballerini, N Balitrand, et al.
Tissue Antigens|February 1, 1975
Combined analysis of three studies of patients with Burkitt's lymphomaJ G Bodmer, W F Bodmer, P Pickbourne, et al.
Cancer|April 15, 1985
Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patientsH Tilly, S Castaigne, D Bordessoule, et al.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1991
[Biological parameters of the efficiency of retinoic acid in acute leukemia]C Chomienne, M Cornic, S Castaigne, et al.
Immunogenetics|January 1, 1986
Correlation between an HLA-DQ alpha length polymorphism of messenger RNA and serologically defined specificities (DQw1, DRw53, DR3+5)P Loiseau, P Lehn, F Dautry, et al.
Blood|October 1, 1986
c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemiaP Lehn, F Sigaux, D Grausz, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Retinoic acids in the treatment of acute promyelocytic leukemiaS Castaigne, C Chomienne, M T Daniel, et al.
Blut|February 1, 1989
alpha-IFN treatment does not induce Ki-ras expression in hairy-cell leukemia patientsM L Giron, G Mercier, F Sigaux, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1984
[Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin]M Marty, G Ganem, J Fischer, et al.
Tissue Antigens|February 1, 1985
Evidence for a new HLA class II determinant present on cells from HLA-DR1 and/or -DR4 individualsV Lepage, D Alcalay, C Douay, et al.
Pageof 34